Logos Global Management as of Dec. 31, 2023
Portfolio Holdings for Logos Global Management
Logos Global Management holds 50 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cytokinetics Com New (CYTK) | 12.7 | $136M | 1.6M | 83.49 | |
| Apellis Pharmaceuticals (APLS) | 10.9 | $117M | 2.0M | 59.86 | |
| Sarepta Therapeutics Call Option (SRPT) | 6.3 | $68M | 700k | 96.43 | |
| Ideaya Biosciences (IDYA) | 6.0 | $64M | 1.8M | 35.58 | |
| Argenx Se Sponsored Adr (ARGX) | 5.1 | $55M | 145k | 380.43 | |
| Olema Pharmaceuticals (OLMA) | 5.1 | $54M | 4.4M | 12.40 | |
| Immunovant (IMVT) | 4.7 | $51M | 1.2M | 42.13 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 4.1 | $44M | 1.1M | 40.76 | |
| Rocket Pharmaceuticals (RCKT) | 3.6 | $38M | 1.3M | 29.97 | |
| Rayzebio | 3.3 | $35M | 568k | 62.17 | |
| Ambrx Biopharma | 2.8 | $30M | 2.1M | 14.24 | |
| Karuna Therapeutics Ord | 2.7 | $29M | 90k | 316.51 | |
| Immunocore Hldgs Ads (IMCR) | 2.6 | $27M | 400k | 68.32 | |
| Dyne Therapeutics (DYN) | 2.3 | $25M | 1.9M | 13.30 | |
| Morphosys Sponsored Ads Call Option (MOR) | 2.3 | $25M | 2.5M | 9.90 | |
| Inhibrx Call Option | 2.1 | $23M | 600k | 38.00 | |
| Annexon (ANNX) | 2.1 | $23M | 5.0M | 4.54 | |
| Akero Therapeutics (AKRO) | 1.7 | $19M | 800k | 23.35 | |
| Ocular Therapeutix (OCUL) | 1.7 | $18M | 4.0M | 4.46 | |
| Design Therapeutics (DSGN) | 1.2 | $13M | 5.0M | 2.65 | |
| Miragen Therapeutics (VRDN) | 1.2 | $13M | 600k | 21.78 | |
| Edgewise Therapeutics (EWTX) | 1.0 | $10M | 950k | 10.94 | |
| Revolution Medicines (RVMD) | 0.9 | $10M | 350k | 28.68 | |
| Acelyrin (SLRN) | 0.9 | $9.3M | 1.3M | 7.46 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.8 | $9.1M | 150k | 60.39 | |
| Atyr Pharma Com New (ATYR) | 0.8 | $8.2M | 5.9M | 1.41 | |
| Iovance Biotherapeutics Call Option (IOVA) | 0.8 | $8.1M | 1.0M | 8.13 | |
| Fulcrum Therapeutics (FULC) | 0.8 | $8.1M | 1.2M | 6.75 | |
| Allakos (ALLK) | 0.7 | $7.9M | 2.9M | 2.73 | |
| Zentalis Pharmaceuticals Call Option (ZNTL) | 0.7 | $7.6M | 500k | 15.15 | |
| Tourmaline Bio (TRML) | 0.7 | $7.4M | 284k | 26.18 | |
| Avidity Biosciences Ord (RNA) | 0.7 | $7.0M | 775k | 9.05 | |
| Silence Therapeutics Ads (SLN) | 0.6 | $6.9M | 400k | 17.37 | |
| Xenon Pharmaceuticals (XENE) | 0.6 | $6.9M | 150k | 46.06 | |
| Neumora Therapeutics (NMRA) | 0.6 | $6.5M | 382k | 17.05 | |
| Arcus Biosciences Incorporated (RCUS) | 0.6 | $6.2M | 325k | 19.10 | |
| Morphic Hldg (MORF) | 0.5 | $5.8M | 200k | 28.88 | |
| Applied Therapeutics (APLT) | 0.5 | $5.6M | 1.7M | 3.35 | |
| Ventyx Biosciences (VTYX) | 0.5 | $4.9M | 2.0M | 2.47 | |
| Icosavax | 0.4 | $4.7M | 300k | 15.76 | |
| Repare Therapeutics Ord (RPTX) | 0.4 | $4.4M | 600k | 7.30 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.4 | $4.4M | 500k | 8.75 | |
| Enliven Therapeutics (ELVN) | 0.4 | $4.2M | 307k | 13.84 | |
| Astria Therapeutics (ATXS) | 0.4 | $4.2M | 545k | 7.68 | |
| Spyre Therapeutics Com New (SYRE) | 0.3 | $3.2M | 150k | 21.52 | |
| Kiniksa Pharmaceuticals Com Cl A | 0.2 | $2.6M | 150k | 17.54 | |
| Delcath Sys Com New (DCTH) | 0.1 | $1.2M | 300k | 4.16 | |
| Io Biotech (IOBT) | 0.1 | $928k | 494k | 1.88 | |
| Immunic (IMUX) | 0.1 | $632k | 421k | 1.50 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $4.0k | 67k | 0.06 |
